Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2023

Synopsys, Inc. +0.19%

Synopsys, Inc.

SNPS

587.40

+0.19%

Results Summary 

  • Record quarterly revenue of $1.599 billion, up approximately 25% year over year. Record fiscal-year revenue of $5.843 billion, up approximately 15% year over year.
  • Quarterly GAAP earnings per diluted share of $2.26; non-GAAP earnings per diluted share of $3.17, which exceeded high end of guidance. Fiscal year GAAP earnings per diluted share of $7.92; non-GAAP earnings per diluted share of $11.19, which exceeded high end of guidance.

SUNNYVALE, Calif., Nov. 29, 2023 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its fourth quarter and fiscal year 2023. Revenue for the fourth quarter of fiscal year 2023 was $1.599 billion, compared to $1.284 billion for the fourth quarter of fiscal year 2022. Revenue for fiscal year 2023 was $5.843 billion, an increase of approximately 15% from $5.082 billion in fiscal year 2022.

Synopsys headquarters in Sunnyvale, Calif. (PRNewsfoto/Synopsys, Inc.)

"In our 37 years as a company, Synopsys has driven a roughly 10 million-fold increase in chip design productivity. This not only enabled the exponential ambition of the semiconductor industry, it, in turn, radically impacted the world," said Aart de Geus, chair and CEO of Synopsys. "Our momentum continued in 2023 as we substantially expanded our AI-driven design differentiation, our semiconductor IP portfolio, and our multi-die system solutions. We also visibly strengthened our customers' differentiation through unique and deep collaborations. Looking ahead, I have great confidence, expectations, and enthusiasm for our future as Sassine Ghazi becomes Synopsys' CEO." 

"Despite global macroeconomic uncertainty, 2023 was a year of record revenue and profitability for Synopsys as silicon R&D and design-starts remain robust. I want to extend my deepest thanks to our team for their stellar execution and to our partners and customers for their commitment," said Sassine Ghazi, president and COO of Synopsys. "We start 2024 with tremendous forward momentum driven by a resilient business model, technology trends – chief among them AI – that create a rising tide for our business, and customers who continue to prioritize investments in the chips and systems that position them for the future. I am profoundly grateful for the opportunity to propel Synopsys to the next wave of growth as its CEO."

"We had strong execution and outperformed our guidance in the fourth quarter, which capped a record financial year for Synopsys. In 2023, on a non-GAAP basis, record earnings per share were up 26% year-over-year, we achieved record operating margins, and expanded our backlog to $8.6 billion," said Synopsys CFO, Shelagh Glaser. "We are confident in our outlook for continued, double-digit revenue growth in the year ahead based on our technology leadership, strong customer momentum and the resiliency of our time-based business model."

GAAP Results

On a U.S. generally accepted accounting principles (GAAP) basis, net income for the fourth quarter of fiscal year 2023 was $349.2 million, or $2.26 per diluted share, compared to $153.5 million, or $0.99 per diluted share, for the fourth quarter of fiscal year 2022. GAAP net income for fiscal year 2023 was $1.230 billion, or $7.92 per diluted share, compared to $984.6 million, or $6.29 per diluted share, for fiscal year 2022.

Non-GAAP Results

On a non-GAAP basis, net income for the fourth quarter of fiscal year 2023 was $490.9 million, or $3.17 per diluted share, compared to non-GAAP net income of $297.7 million, or $1.91 per diluted share, for the fourth quarter of fiscal year 2022. Non-GAAP net income for fiscal year 2023 was $1.737 billion, or $11.19 per diluted share, compared to non-GAAP net income of $1.393 billion, or $8.90 per diluted share, for fiscal year 2022.

For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below. 

Business Segments 

Synopsys reports revenue and operating income in three segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array (FPGA) IC design software, verification software and hardware products, manufacturing software products and other; (2) Design IP, which includes our Design IP products; and (3) Software Integrity, which includes solutions that test software code for security vulnerabilities and quality defects, as well as professional and managed services. Further information regarding these segments is provided at the end of this press release.

Financial Targets 

Synopsys also provided its consolidated financial targets for the first quarter and full fiscal year 2024. The fiscal year targets include the impact of an extra week in fiscal year 2024, which will be included in the first quarter of fiscal year 2024. These financial targets assume no further changes to export control restrictions or the current U.S. government "Entity List" restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see "Forward-Looking Statements" below. 

First Quarter and Full Fiscal Year 2024 Financial Targets (1)

(in millions except per share amounts)















 Range for Three Months Ending



Range for Fiscal Year Ending



January 31, 2024



October 31, 2024



Low

High



Low

High

Revenue

$             1,630

$             1,660



$             6,570

$             6,630

GAAP Expenses

$             1,217

$             1,237



$             4,995

$             5,052

Non-GAAP Expenses

$             1,017

$             1,027



$             4,140

$             4,180

Non-GAAP Other Income (Expense)

$                     -

$                   2



$                   4

$                   8

Non-GAAP Tax Rate

15 %

15 %



15 %

15 %

Outstanding Shares (fully diluted)

155

157



155

157

GAAP EPS

$               2.40

$               2.50



$               9.07

$               9.25

Non-GAAP EPS

$               3.40

$               3.45



$             13.33

$             13.41

Operating Cash Flow







~ $1,400













(1) Synopsys' first quarter of fiscal year 2024 has one extra week and will end on February 3, 2024. Fiscal year 2024 will end on

November 2, 2024. For presentation purposes, we refer to the closest calendar month end.

For a reconciliation of Synopsys' first quarter and fiscal year 2024 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see "GAAP to Non-GAAP Reconciliation" in the accompanying tables below. 

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys' corporate website at www.investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the first quarter of fiscal year 2024 in February 2024. 

Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys' corporate website at www.synopsys.com (collectively, the "Earnings Materials"), represent Synopsys' expectations and beliefs as of November 29, 2023. Although these Earnings Materials will remain available on Synopsys' website through the date of the earnings call for the first quarter of fiscal year 2024, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

Availability of Final Financial Statements

Synopsys will include final financial statements for the fiscal year 2023 in its annual report on Form 10-K to be filed on or before December 27, 2023.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software™ partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry's broadest portfolio of application security testing tools and services. Whether you're a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP, but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys' operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. These non-GAAP measures may be different from non-GAAP measures used by other companies. Synopsys' management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys' management believes it is useful for itself and investors to review, as applicable, both GAAP financial measures that include: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related items, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments, in each case as described further in Item 2.02 of Synopsys' Current Report on Form 8-K filed on November 29, 2023. In addition, the non-GAAP financial measures that exclude such information help facilitate internal comparisons to Synopsys' historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors' operating results.

Synopsys utilizes an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect Synopsys' normal operations, and to more closely align its tax rate with its expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of Synopsys' historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, Synopsys has elected to adopt a non-GAAP tax rate of 15% for fiscal year 2024.

When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of Synopsys' Current Report on Form 8-K filed on November 29, 2023, for additional information about the measures Synopsys uses to evaluate its core business operations. Synopsys is unable to provide a reconciliation of certain non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis because doing so would not be possible without unreasonable effort due to, among other things, the potential variability and limited visibility of the excluded items. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information. 

Reconciliation of Fourth Quarter and Fiscal Year 2023 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per diluted share for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Fourth Quarter Fiscal Year 2023 Results(1)

(unaudited and in thousands, except per share amounts)













Three Months Ended

Twelve Months Ended



October 31,

October 31,



2023

2022

2023

2022

GAAP net income attributed to Synopsys

$         349,190

$         153,500

$       1,229,888

$         984,594

Adjustments:









Amortization of intangible assets

26,949

25,530

98,790

95,711

Stock compensation

140,989

125,339

561,928

458,776

Acquisition-related items

5,269

(2,063)

15,115

9,269

Restructuring charges

(1,382)

77,002

12,057

Tax settlement

(23,752)

Tax adjustments

(30,072)

(4,618)

(222,204)

(167,582)

Non-GAAP net income attributed to Synopsys

$         490,943

$         297,688

$       1,736,767

$       1,392,825

































Three Months Ended

Twelve Months Ended



October 31,

October 31,



2023

2022

2023

2022

GAAP net income per diluted share attributed to

Synopsys

$               2.26

$               0.99

$               7.92

$               6.29

Adjustments:









Amortization of intangible assets

0.17

0.16

0.64

0.61

Stock compensation

0.91

0.80

3.62

2.93

Acquisition-related items

0.03

(0.01)

0.10

0.06

Restructuring charges

(0.01)

0.50

0.08

Tax settlement

(0.15)

Tax adjustments

(0.19)

(0.03)

(1.44)

(1.07)

Non-GAAP net income per diluted share attributed

to Synopsys

$               3.17

$               1.91

$             11.19

$               8.90





















Shares used in computing net income per diluted

share amounts:

154,845

155,749

155,195

156,485











(1) Synopsys' fourth quarter of fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation

purposes, we refer to the closest calendar month end.

 

GAAP to Non-GAAP Tax Rate Reconciliation (1)

(unaudited)







Twelve Months Ended



October 31, 2023





GAAP effective tax rate

6.4 %

Stock compensation

3.3 %

Tax settlement

1.8 %

Tax adjustments (2)

4.5 %

Non-GAAP effective tax rate

16.0 %





(1) Synopsys' fiscal year 2023 ended on October 28, 2023. For presentation purposes, we refer to the closest

calendar month end.

(2) The adjustments are primarily related to the differences in the tax rate effect of certain deductions, such as the

deduction for foreign-derived intangible income and credits.

Reconciliation of 2024 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2024 Targets (1)

(in thousands, except per share amounts)













 Range for Three Months Ending



January 31, 2024



Low

High

Target GAAP expenses

$           1,217,000

$           1,237,000

Adjustments:





    Amortization of intangible assets

(26,000)

(29,000)

    Stock compensation

(174,000)

(181,000)

Target non-GAAP expenses

$           1,017,000

$           1,027,000



















Range for Three Months Ending



January 31, 2024



Low

High

Target GAAP earnings per diluted share attributed to Synopsys

$                   2.40

$                   2.50

Adjustments:





    Amortization of intangible assets

0.19

0.17

    Stock compensation

1.16

1.12

    Tax adjustments

(0.35)

(0.34)

Target non-GAAP earnings per diluted share attributed to Synopsys    

$                   3.40

$                   3.45







Shares used in non-GAAP calculation (midpoint of target range)

156,000

156,000

 

GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2024 Targets (1)

(in thousands, except per share amounts)













Range for Fiscal Year Ending



October 31, 2024



Low

High

Target GAAP expenses

$           4,995,000

$           5,052,000

Adjustments:





    Amortization of intangible assets

(103,000)

(108,000)

    Stock compensation

(752,000)

(764,000)

Target non-GAAP expenses

$           4,140,000

$           4,180,000



















Range for Fiscal Year Ending



October 31, 2024



Low

High

Target GAAP earnings per diluted share attributed to

Synopsys

$                   9.07

$                   9.25

Adjustments:





    Amortization of intangible assets

0.69

0.66

    Stock compensation

4.90

4.82

    Tax adjustments

(1.33)

(1.32)

Target non-GAAP earnings per diluted share attributed

to Synopsys

$                 13.33

$                 13.41







Shares used in non-GAAP calculation (midpoint of

target range)

156,000

156,000







(1) Synopsys' first quarter of fiscal year 2024 has one extra week and will end on February 3, 2024. Fiscal year 2024 will end

on November 2, 2024. For presentation purposes, we refer to the closest calendar month end.

Forward-Looking Statements

This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding Synopsys' executive management transition, short-term and long-term financial targets, expectations and objectives; strategies related to our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; the expected impact of U.S. and foreign government actions and regulatory changes, including export control restrictions on our financial results; the potential impact of the uncertain macroeconomic and geopolitical environment on our financial results; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; software trends; planned acquisitions and stock repurchases; our expected tax rate; and the impact and result of pending legal, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S. or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys' results is included in filings we make with the SEC from time to time, including in the sections entitled "Risk Factors" in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys' most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys' financial results for its fourth quarter and fiscal year 2023 are not necessarily indicative of Synopsys' operating results for any future periods. The information provided herein is as of November 29, 2023. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

SYNOPSYS, INC.

Unaudited Consolidated Statements of Income (1)

(in thousands, except per share amounts)



























Three Months Ended



Twelve Months Ended



October 31,



October 31,



2023

2022



2023

2022

Revenue:











  Time-based products

$               870,249

$               808,160



$             3,383,632

$             2,993,786

  Upfront products

449,181

253,245



1,429,330

1,226,728

  Total products revenue

1,319,430

1,061,405



4,812,962

4,220,514

  Maintenance and service

279,698

222,887



1,029,657

861,028

    Total revenue

1,599,128

1,284,292



5,842,619

5,081,542

Cost of revenue:











  Products

213,586

173,617



763,494

653,783

  Maintenance and service

98,779

89,313



383,835

342,978

  Amortization of intangible assets

19,978

19,791



74,864

66,936

    Total cost of revenue

332,343

282,721



1,222,193

1,063,697

Gross margin

1,266,785

1,001,571



4,620,426

4,017,845

Operating expenses:











  Research and development

488,485

461,618



1,946,813

1,680,379

  Sales and marketing

228,982

208,448



889,016

779,777

  General and administrative

112,150

107,414



410,311

353,840

  Amortization of intangible assets

8,029

6,718



28,025

29,754

  Restructuring charges

(1,382)



77,002

12,057

    Total operating expenses

836,264

784,198



3,351,167

2,855,807

Operating income

430,521

217,373



1,269,259

1,162,038

Other income (expense), net

(20,830)

(5,244)



32,523

(46,524)

Income before income taxes

409,691

212,129



1,301,782

1,115,514

Provision (benefit) for income taxes

63,196

60,572



83,657

137,078

Net income

346,495

151,557



1,218,125

978,436

Net income (loss) attributed to non-controlling interest

and redeemable non-controlling interest

(2,695)

(1,943)



(11,763)

(6,158)

Net income attributed to Synopsys

$               349,190

$               153,500



$             1,229,888

$               984,594

























Net income per share attributed to Synopsys:











  Basic

$                      2.30

$                     1.00



$                     8.08

$                     6.44

  Diluted

$                      2.26

$                     0.99



$                     7.92

$                     6.29













Shares used in computing per share amounts:











  Basic

151,972

152,761



152,146

153,002

  Diluted

154,845

155,749



155,195

156,485













(1) Synopsys' fourth quarter of fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we

refer to the closest calendar month end.

 

SYNOPSYS, INC.

Unaudited Consolidated Balance Sheets (1)

(in thousands, except par value amounts)









October 31, 2023

October 31, 2022

ASSETS:





Current assets:





  Cash and cash equivalents

$             1,438,913

$             1,417,608

  Short-term investments

151,639

147,913

        Total cash, cash equivalents and short-term investments

1,590,552

1,565,521

  Accounts receivable, net

946,967

796,091

  Inventories

325,590

211,927

  Prepaid and other current assets

567,515

439,130

        Total current assets

3,430,624

3,012,669

Property and equipment, net

557,261

483,300

Operating lease right-of-use assets, net

568,829

559,090

Goodwill

4,070,336

3,842,234

Intangible assets, net

374,194

386,446

Deferred income taxes

860,914

670,653

Other long-term assets

470,973

463,695

          Total assets

$           10,333,131

$             9,418,087







LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND

STOCKHOLDERS' EQUITY:





Current liabilities:





  Accounts payable and accrued liabilities

$             1,123,761

$               809,403

  Operating lease liabilities

85,690

54,274

  Deferred revenue

1,776,000

1,910,822

          Total current liabilities

2,985,451

2,774,499

Long-term operating lease liabilities

584,035

581,273

Long-term deferred revenue

175,128

154,472

Long-term debt

18,078

20,824

Other long-term liabilities

386,138

327,829

          Total liabilities

4,148,830

3,858,897

Redeemable non-controlling interest

31,043

38,664

Stockholders' equity:





  Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

  Common stock, $0.01 par value: 400,000 shares authorized; 152,053 and 152,375 shares

outstanding, respectively

1,521

1,524

  Capital in excess of par value

1,276,152

1,487,126

  Retained earnings

6,741,699

5,534,307

  Treasury stock, at cost: 5,207 and 4,886 shares, respectively

(1,675,650)

(1,272,955)

  Accumulated other comprehensive income (loss)

(196,414)

(234,277)

          Total Synopsys stockholders' equity

6,147,308

5,515,725

Non-controlling interest

5,950

4,801

          Total stockholders' equity

6,153,258

5,520,526

          Total liabilities, redeemable non-controlling interest and stockholders' equity

$           10,333,131

$             9,418,087







(1) Synopsys' fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to the

closest calendar month end.

 

SYNOPSYS, INC.

Unaudited Condensed Consolidated Statements of Cash Flows (1)

(in thousands)











Twelve Months Ended October 31,



2023



2022

CASH FLOWS FROM OPERATING ACTIVITIES:







Net income

$         1,218,125



$             978,436

Adjustments to reconcile net income to net cash provided by operating activities:







Amortization and depreciation

247,120



228,405

Reduction of operating lease right-of-use assets

97,705



89,541

Amortization of capitalized costs to obtain revenue contracts

82,190



73,026

Stock-based compensation

563,292



459,029

Allowance for credit losses

19,932



(3,477)

Deferred income taxes

(211,045)



(36,913)

Other non-cash

13,295



10,188

Net changes in operating assets and liabilities, net of acquired assets and assumed

liabilities:







Accounts receivable

(178,432)



(251,390)

Inventories

(123,752)



1,320

Prepaid and other current assets

(106,396)



(89,983)

Other long-term assets

(100,618)



(15,283)

Accounts payable and accrued liabilities

170,496



(34,066)

Operating lease liabilities

(73,281)



(85,828)

Income taxes

198,078



1,644

Deferred revenue

(113,435)



414,251

Net cash provided by operating activities

1,703,274



1,738,900









CASH FLOWS FROM INVESTING ACTIVITIES:







Proceeds from sales and maturities of short-term investments

130,435



93,696

Purchases of short-term investments

(131,079)



(97,245)

Proceeds from sales of long-term investments

8,492



582

Purchases of long-term investments

(435)



(7,000)

Purchases of property and equipment

(189,618)



(136,589)

Acquisitions, net of cash acquired

(297,692)



(422,374)

Capitalization of software development costs

(2,204)



(2,493)

Other



(1,200)

Net cash used in investing activities

(482,101)



(572,623)









CASH FLOWS FROM FINANCING ACTIVITIES:







Repayment of debt

(2,603)



(76,838)

Issuances of common stock

252,986



237,956

Payments for taxes related to net share settlement of equity awards

(241,408)



(174,005)

Purchase of equity forward contract

(45,000)



Purchases of treasury stock

(1,160,724)



(1,100,000)

Other

(122)



(3,413)

Net cash used in financing activities

(1,196,871)



(1,116,300)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,979)



(65,296)

Net change in cash, cash equivalents and restricted cash

21,323



(15,319)

Cash, cash equivalents and restricted cash, beginning of year

1,419,864



1,435,183

Cash, cash equivalents and restricted cash, end of period

$         1,441,187



$         1,419,864









(1) Synopsys' fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer

to the closest calendar month end.

 

SYNOPSYS, INC.

Business Segment Reporting (1)(2)

(in millions)













Three Months Ended

October 31, 2023

Three Months Ended

October 31, 2022

Twelve Months Ended

October 31, 2023

Twelve Months Ended

October 31, 2022



Revenue by segment









- Design Automation

$                           953.7

$                           862.1

$                         3,775.3

$                         3,300.2

% of Total

59.7 %

67.1 %

64.6 %

64.9 %

- Design IP

$                           513.7

$                           295.2

$                         1,542.7

$                         1,315.5

% of Total

32.1 %

23.0 %

26.4 %

25.9 %

- Software Integrity

$                           131.7

$                           127.1

$                           524.6

$                           465.8

% of Total

8.2 %

9.9 %

9.0 %

9.2 %

Total segment revenue

$                         1,599.1

$                         1,284.3

$                         5,842.6

$                         5,081.5











Adjusted operating income by segment









- Design Automation

$                           317.9

$                           294.7

$                         1,439.7

$                         1,206.6

- Design IP

$                           241.4

$                             48.1

$                           532.1

$                           421.5

- Software Integrity

$                             20.0

$                             10.7

$                             76.3

$                             47.0

Total adjusted segment operating income

$                          579.4

$                           353.4

$                         2,048.0

$                         1,675.1











Adjusted operating margin by segment









- Design Automation

33.3 %

34.2 %

38.1 %

36.6 %

- Design IP

47.0 %

16.3 %

34.5 %

32.0 %

- Software Integrity

15.2 %

8.4 %

14.5 %

10.1 %

Total adjusted segment operating margin    

36.2 %

27.5 %

35.1 %

33.0 %

 

Total Adjusted Segment Operating Income Reconciliation (1)(2)(3)

(in millions)













Three Months Ended

October 31, 2023

Three Months Ended

October 31, 2022

Twelve Months Ended

October 31, 2023

Twelve Months Ended

October 31, 2022



GAAP total operating income – as reported

$                           430.5

$                           217.4

$                       1,269.3

$                       1,162.0

Other expenses managed at consolidated level









-Amortization of intangible assets (4)

28.0

26.5

102.9

96.7

-Stock compensation (4)

141.3

125.6

563.3

459.0

-Non-qualified deferred compensation plan

(24.4)

(18.8)

20.5

(68.8)

-Acquisition-related items (5)

5.3

2.7

15.1

14.1

-Restructuring charges

(1.4)

77.0

12.1

Total adjusted segment operating income

$                           579.4

$                           353.4

$                       2,048.0

$                       1,675.1











(1) Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our

business. Amounts may not foot due to rounding.

(2) Synopsys' fourth quarter of fiscal year 2023 and 2022 ended on October 28, 2023 and October 29, 2022, respectively. For presentation purposes, we refer to

the closest calendar month end.

(3) These segments results are consistent with the information required by ASC 280, Segment Reporting. Synopsys' chief operating decision maker (CODM) is

our Chief Executive Officer. The CODM does not allocate certain operating expenses managed at a consolidated level to our reportable segments and, as a result,

the reported operating income and operating margin do not include these unallocated expenses as shown in the table above.

(4) The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

(5) The adjustment excludes the gains from the mark-up of a cost method investment to fair value upon obtaining control through the acquisition recorded in other

income (expense).

INVESTOR CONTACT:

Trey Campbell

Synopsys, Inc.

650-584-4289

Synopsys-ir@synopsys.com 

EDITORIAL CONTACT:

Cara Walker

Synopsys, Inc.

650-584-5000

corp-pr@synopsys.com

Synopsys (PRNewsfoto/Synopsys)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2023-302001040.html

SOURCE Synopsys, Inc.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via